Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
38.10
+0.09 (0.24%)
At close: Jun 26, 2026, 4:00 PM EDT
38.39
+0.29 (0.76%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Cogent Biosciences Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Cogent Biosciences stock have an average target of 51.7, with a low estimate of 35 and a high estimate of 60. The average target predicts an increase of 35.70% from the current stock price of 38.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cogent Biosciences stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $55 | Buy | Reiterates | $55 | +44.36% | Jun 17, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $45 | Buy | Maintains | $45 | +18.11% | Jun 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $55 | Buy | Maintains | $55 | +44.36% | Jun 15, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 1, 2026 |
| UBS | UBS | Buy Maintains $60 | Buy | Maintains | $60 | +57.48% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
9.46M
Revenue Next Year
345.31M
from 9.46M
Increased by 3,549.72%
EPS This Year
-2.26
from -2.11
EPS Next Year
-0.96
from -2.26
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.1M | 790.7M | |
| Avg | 9.5M | 345.3M | |
| Low | n/a | 107.4M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 8,257.2% | 226.1% |
| Avg | 3,549.7% | 111.4% |
| Low | 1,035.2% | -27.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.96 | 1.29 | |
| Avg | -2.26 | -0.96 | |
| Low | -2.70 | -2.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.